allowance for doubtful accounts of nil and US$6,334,832 for three
months ended March 31, 2013 and 2012, respectively4,069,972(2,209,471)Income from operations1,135,39721,910,181Other (expenses)/incomeInterest expenses(1,866,378)(1,004,169)Interest income165,75860,074Other (expenses)/income, net(64,336)32,054Change in fair value of derivative liabilities-59,398Total other income, net(1,764,956)(852,643)(Losses)/earnings before income tax expense(629,559)21,057,538Income tax (benefit)/expense(5,079)3,740,222Net (loss)/income(624,480)17,317,316Less: Net (loss)/income attributable to the noncontrolling
interest(11,908)935,026Net (loss)/income attributable to Yongye International, Inc.
16,382,290Net (loss)/income per share of common stock
0.27Weighted average shares used in computation:
Diluted 50,669,88049,460,252Net (loss)/income(624,480)17,317,316Other comprehensive incomeForeign currency translation adjustment, net of US$ nil
income taxes2,663,2362,341,251Comprehensive income2,038,75619,658,567Less: Comprehensive income attributable to the noncontrolling
interest114,0801,043,895Comprehensive income attributable to Yongye International, Inc.
18,614,672YONGYE INTERNATIONAL, INC. AND SUBSIDIARIESCONSOLIDATED STATEMENTS OF CASH FLOWSFor the Three Months EndedMarch 31, 2013 March 31, 2012
SOURCE Yongye International, Inc.
Copyright©2012 PR Newswire.
All rights reserved
Related biology technology :
1. Yongye International to Report First Quarter 2013 Financial Results on May 10, 2013
2. Yongye International Announces Second Quarter 2012 Financial Results
3. Yongye International to Report Second Quarter 2012 Financial Results on August 9, 2012
4. Dr. Szczepan Baran will be Presenting at the International Microsurgical Simulation Society at Columbia University in New York
5. Dyadic International To Announce First Quarter 2013 Financial Results And Host Conference Call On Wednesday, May 15, 2013
6. Celladon Corporation and SIRO Clinpharm Announce Presentation at "Statisticians in the Pharmaceutical Industry International Conference"
7. Lisa Lorraine Reyes Muñoz, GeneCell International’s Physician Relation's Manager Launches Educational Meetings for General Public on Umbilical Cord Blood Stem Cells
8. Danai Brooks Joins Dyadic International as Chief Operating Officer
9. PAREXEL International Announces Acquisition of HERON Group LTD, A Leading Commercialization Consultancy
10. PAREXEL International Reports Third Quarter Fiscal Year 2013 Results
11. GeneCell International Gives Back to the Community by Participating in Local Elementary School’s Career Day